The Cure Sickle Cell Initiative: Catalyzing Progress via Innovative Interfaces Between NIH, Patients, Academics, ASH, and the Private Sector
Dr. Edward Benz provides some background on the discovery of sickle cell disease and development of the Cure Sickle Cell Initiative. Dr. Ify Osunkwo adds further perspectiv
A New Standard of Care for Children and Young Adults With T-cell Acute Lymphoblastic Leukemia
Dr. Teachey reviews a study that shows outstanding outcomes for children and young adults with T-cell acute lymphoblastic leukemia that have raised the bar and established
In her last President's Column, Dr. Alexis Thompson looks back on a year full of change and advancement through a series of initiatives and provides a glimpse of what's to come in 2019 and beyond.
Dr. Thompson shares her experience traveling to Ghana as part of ASH's efforts to reduce SCD-related mortality by promoting newborn screening and early intervention in sub-Saharan African countries.
Dr. Thompson discusses ASH's advocacy efforts in support of programs and policies that enable the Society to deliver change to patients and their families worldwide.
Dr. Thompson discusses ASH sickle cell disease (SCD) initiatives as part of ASH's mission to help those who treat SCD patients provide quality care, continue their professional development, and enhance their knowledge and expertise.
Dr. Thompson discusses the many global initiatives that define ASH's international efforts as well as the Society's global reach as a powerful reflection of it's mission.
In her first President's Column, Dr. Alexis Thompson ushers in 2018 with a discussion of annual meeting media highlights.
In his final President's Column as ASH President, Dr. Ken Anderson provides a thorough overview of ASH's research agenda including topics such as precision medicine, improving the state of care for VTE, epigenetic mechanisms, and stem cell biology and regenerative medicine.
Dr. Ken Anderson discusses ASH's role in health care reform.
Dr. Anderson outlines six major ASH strategic initiatives and goals for the coming years discussed at the 2017 Executive Committee Spring Retreat in Canada.
Dr. Anderson discusses ASH's plan to participate in the "March for Science" to advocate for innovation and education through adequate research funding.
November-December 2018Volume 15, Issue 6
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology